- Home
- INTS vs WETH Comparison
INTS vs WETH Comparison
Compare INTS & WETH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTS
- WETH
- Stock Information
- Founded
- INTS 2012
- WETH 1992
- Country
- INTS United States
- WETH China
- Employees
- INTS N/A
- WETH N/A
- Industry
- INTS Biotechnology: Pharmaceutical Preparations
- WETH
- Sector
- INTS Health Care
- WETH
- Exchange
- INTS Nasdaq
- WETH Nasdaq
- Market Cap
- INTS 12.2M
- WETH 10.9M
- IPO Year
- INTS 2023
- WETH N/A
- Fundamental
- Price
- INTS $0.31
- WETH $1.61
- Analyst Decision
- INTS Strong Buy
- WETH
- Analyst Count
- INTS 4
- WETH 0
- Target Price
- INTS $4.50
- WETH N/A
- AVG Volume (30 Days)
- INTS 5.0M
- WETH 269.3K
- Earning Date
- INTS 11-12-2025
- WETH 10-09-2025
- Dividend Yield
- INTS N/A
- WETH N/A
- EPS Growth
- INTS N/A
- WETH 63.71
- EPS
- INTS N/A
- WETH 0.63
- Revenue
- INTS N/A
- WETH $42,877,572.00
- Revenue This Year
- INTS N/A
- WETH N/A
- Revenue Next Year
- INTS N/A
- WETH N/A
- P/E Ratio
- INTS N/A
- WETH $2.49
- Revenue Growth
- INTS N/A
- WETH 5.58
- 52 Week Low
- INTS $0.19
- WETH $0.76
- 52 Week High
- INTS $3.75
- WETH $2.20
- Technical
- Relative Strength Index (RSI)
- INTS 64.31
- WETH 75.43
- Support Level
- INTS $0.27
- WETH $1.16
- Resistance Level
- INTS $0.30
- WETH $1.77
- Average True Range (ATR)
- INTS 0.03
- WETH 0.17
- MACD
- INTS 0.01
- WETH 0.03
- Stochastic Oscillator
- INTS 60.25
- WETH 76.19
About INTS Intensity Therapeutics Inc. Common stock
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.
About WETH Wetouch Technology Inc.
Wetouch Technology Inc is a touch panel supplier focused on R & D, production and sales of touch screen products. It offers touchscreens for a variety of applications, including GPS/car entertainment panels for automotive industry, industrial human-machine interface, financial and banking terminals, point of sale, lottery and gaming machines, smart home, robots and charging stations. The company sells touchscreen products both domestically in China and internationally, covering the majority of areas in China, Taiwan, South Korea, and Germany.